<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Publication:
Human CRY1 variants associate with attention deficit/hyperactivity disorder

Loading...
Thumbnail Image

School / College / Institute

Item type:Organizational Unit,
Item type:Organizational Unit,
Item type:Organizational Unit,
Item type:Organizational Unit,

Program

Organization Authors

Co-Authors

Onat, O. Emre

Kars, M. Ece

Bilguvar, Kaya

Wu, Yiming

Özhan, Ayşe

Trusso, M. Allegra

Goracci, Arianna

Fallerini, Chiara

Renieri, Alessandra

Casanova, Jean Laurent

Date

Language

Embargo Status

NO

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Attention deficit/hyperactivity disorder (ADHD) is a common and heritable phenotype frequently accompanied by insomnia, anxiety, and depression. Here, using a reverse phenotyping approach, we report heterozygous coding variations in the core circadian clock gene cryptochrome 1 in 15 unrelated multigenerational families with combined ADHD and insomnia. The variants led to functional alterations in the circadian molecular rhythms, providing a mechanistic link to the behavioral symptoms. One variant, CRY1Δ11 c.1657+3A&gt;C, is present in approximately 1% of Europeans, therefore standing out as a diagnostic and therapeutic marker. We showed by exome sequencing in an independent cohort of patients with combined ADHD and insomnia that 8 of 62 patients and 0 of 369 controls carried CRY1Δ11. Also, we identified a variant, CRY1Δ6 c.825+1G&gt;A, that shows reduced affinity for BMAL1/CLOCK and causes an arrhythmic phenotype. Genotype-phenotype correlation analysis revealed that this variant segregated with ADHD and delayed sleep phase disorder (DSPD) in the affected family. Finally, we found in a phenome-wide association study involving 9438 unrelated adult Europeans that CRY1Δ11 was associated with major depressive disorder, insomnia, and anxiety. These results defined a distinctive group of circadian psychiatric phenotypes that we propose to designate as "circiatric" disorders.

Source

Publisher

American Society for Clinical Investigation (ASCI)

Citation

item.page.haspartof

Source

Journal of Clinical Investigation

item.page.ispartofseries

item.page.edition

DOI

10.1172/JCI135500

item.page.datauri

item.page.link

Rights

Copyrights Note

Endorsement

Review

Supplemented By

Referenced By

Related Patent

Related Goal

Item type:Goal, Access status: Open Access ,
03 - Good Health and Well-being
Over the last 15 years, the number of childhood deaths has been cut in half. This proves that it is possible to win the fight against almost every disease. Still, we are spending an astonishing amount of money and resources on treating illnesses that are surprisingly easy to prevent. The new goal for worldwide Good Health promotes healthy lifestyles, preventive measures and modern, efficient healthcare for everyone.
Google Scholar
Scholar'da Ara ↗
3
Görüntülenme
19
İndirme
Altmetric
Dimensions
PlumX Metrikleri
BIP! Indicators